Unicycive Therapeutics Files Q1 2025 10-Q

Ticker: UNCY · Form: 10-Q · Filed: May 14, 2025 · CIK: 1766140

Unicycive Therapeutics, Inc. 10-Q Filing Summary
FieldDetail
CompanyUnicycive Therapeutics, Inc. (UNCY)
Form Type10-Q
Filed DateMay 14, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, quarterly-report, pharmaceuticals

TL;DR

Unicycive Therapeutics filed its Q1 2025 10-Q. Check financials.

AI Summary

Unicycive Therapeutics, Inc. filed its quarterly report on Form 10-Q for the period ended March 31, 2025. The company, incorporated in Delaware, is in the pharmaceutical preparations industry and is headquartered in Los Altos, California. This filing provides an update on the company's financial and operational status for the first quarter of 2025.

Why It Matters

This filing provides investors and the public with the latest financial and operational details for Unicycive Therapeutics, Inc., crucial for understanding the company's performance and outlook.

Risk Assessment

Risk Level: medium — As a pharmaceutical company, Unicycive Therapeutics is subject to inherent risks related to drug development, regulatory approvals, and market competition.

Key Players & Entities

  • Unicycive Therapeutics, Inc. (company) — Registrant
  • March 31, 2025 (date) — Quarterly period end date
  • 20250514 (date) — Filing date
  • 001-40582 (other) — Commission file number
  • Los Altos, CA (location) — Company headquarters

FAQ

What is the primary business of Unicycive Therapeutics, Inc.?

Unicycive Therapeutics, Inc. is in the Pharmaceutical Preparations industry, SIC code 2834.

When is the period covered by this 10-Q filing?

The quarterly period covered by this filing is ended March 31, 2025.

What is the company's commission file number?

The commission file number for Unicycive Therapeutics, Inc. is 001-40582.

Where is Unicycive Therapeutics, Inc. located?

The company's principal executive offices are located at 4300 El Camino Real, Suite 210, Los Altos, CA 94022.

What is the state of incorporation for Unicycive Therapeutics, Inc.?

Unicycive Therapeutics, Inc. is incorporated in Delaware.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding Unicycive Therapeutics, Inc. (UNCY).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.